The potential of Metabolomics in assessing global compositional changes resulting from the application of CRISPR/Cas9 technologies (2022)

First Author: Drapal M

Attributed to: 21EBTA: Engineering plant cell factories for the production of biomedicines and their ingredients. (Acronym; Celfacto) funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-2287743/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-2287743/v1

Type: Preprint